“COVID-19 in Tralokinumab-Treated Patients With Moderate-to- Severe Atopic Dermatitis: Case Series from the ECZTEND Long- Term Extension Trial”. 2021. SKIN The Journal of Cutaneous Medicine 5 (6): s58. https://doi.org/10.25251/skin.5.supp.58.